Latest / Health & Veritas: Yale's Healthcare and Health Policy Podcast
Evan Sussman: Expanding Access to Fertility Drugs
Howie and Harlan welcome Evan Sussman, the CEO of Granata Bio, which aims to bring IVF and fertility drugs that have been proven in other markets to the United States. Harlan reports on Elon Musk's Neuralink, which will test a technology to restore rudimentary sight to the blind; Howie tries to reconcile conflicting reports about the viability of the Medicare trust fund.
Links:
Neuralink
"Elon Musk announces Neuralink's first human implant of Blindsight coming this year"
"Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant"
"Elon Musk's Neuralink receives Canadian…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.